PerpEquities

Equity · Consumer defensive

Kenvue Inc. (KVUE) perpetual futures

Kenvue Inc. is a global consumer health company offering products in self care, skin health and beauty, and essential health, with brands like Tylenol, Neutrogena, and Listerine.

+0.7%NYSE closed
Open in terminal

Price chart

Interactive TradingView chart

TradingView symbol NYSE:KVUE

Loads TradingView's third-party widget (about 1 MB) on demand.

Auto: underlying reference priceOpen in TradingView

Trading data

Perpetual market activity

0/1 live markets
Venues
1
Live markets
0/1
24h volume
-
Open interest
-
Best liquidity
-
Tightest spread
-
Highest volume
-
Settlement mix
USDT · 1/1
Perp/spot vol.
-
OI / float
-
Spot performance
1D+0.73%
5D+1.19%
1M+0.28%
6M+2.77%
YTD+3.36%
1Y+9.93%

Venue matrix

1 markets

Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.

Trade
BingXTradeKVUE-USDTWatchlist------USDT-
Best venues for this underlying

Best liquidity

-
No live data-

Tightest spread

-
No live data-

Highest volume

-
No live data-

Company data

Company fundamentals

Updated 23m ago
Market cap
$34.2B
Updated 23m ago
Revenue
$15.4B
Trailing 12 months
Revenue growth
+3%
Next fiscal year
Profit margin
+10.8%
P/E
20.5
Peer P/E 24.8
Free cash flow
$2.1B
Trailing 12 months
More metrics
Net income
$1.7B
Trailing 12 months
P/S
2.2
Peer P/E
24.8
Similar listed perps
Revenue estimate
$15.6B
Next fiscal year
Earnings
2026-11-02
Revenue est. $3.9B · Updated 23m ago
Dividend
$0.21
2026-09-21

Fundamental detail

Annual + quarterly
Latest revenue$15.1B
Net margin+9.7%
Free cash flow$1.7B
Net debt$7.5B
2020$14.5B
2021$15.1B
2022$15B
2023$15.4B
2024$15.5B
2025$15.1B
PeriodRevenueGrowthNet incomeFCF
2020$14.5B+1%-$879M$3.2B
2021$15.1B+4%$2.1B$39M
2022$15B-1%$2.1B$2.2B
2023$15.4B+3%$1.7B$2.7B
2024$15.5B0%$1B$1.3B
2025$15.1B-2%$1.5B$1.7B
PeriodGross marginOperating marginNet marginROEROA
2020+54.2%-6.8%-6.1%-4.8%-3.0%
2021+55.9%+19.4%+13.8%+10.2%+7.4%
2022+55.4%+17.9%+13.8%+10.3%+7.6%
2023+56.0%+16.3%+10.8%+14.8%+6.0%
2024+58.0%+11.9%+6.7%+10.7%+4.0%
2025+58.1%+17.9%+9.7%+13.7%+5.4%
PeriodCashDebtNet debtCurrent ratio
2020$618M$0-$618M0.61
2021$740M$129M-$611M1.22
2022$1.2B$9B$7.8B1.50
2023$1.4B$8.4B$7B1.12
2024$1.1B$8.7B$7.6B0.96
2025$1.1B$8.5B$7.5B0.96
PeriodMarket capEnterprise valueP/SP/E
2020$50.8B$50.2B3.5-57.2
2021$50.8B$50.2B3.424.5
2022$51.5B$59.3B3.424.9
2023$39.8B$46.9B2.623.9
2024$40.6B$48.2B2.639.2
2025$33B$40.4B2.222.3
Q3 2024$3.9B
Q4 2024$3.7B
Q1 2025$3.7B
Q2 2025$3.8B
Q3 2025$3.8B
Q4 2025$3.8B
Q1 2026$3.9B
Q2 2026$4B
PeriodRevenueGrowthNet incomeFCF
Q3 2024$3.9B0%$383M$190M
Q4 2024$3.7B0%$293M$661M
Q1 2025$3.7B-4%$322M$249M
Q2 2025$3.8B-4%$420M$533M
Q3 2025$3.8B-3%$398M$196M
Q4 2025$3.8B+3%$330M$744M
Q1 2026$3.9B+4%$474M$350M
Q2 2026$4B+3%$456M$826.8M
PeriodGross marginOperating marginNet marginROEROA
Q3 2024+58.5%+16.8%+9.8%+3.6%+1.4%
Q4 2024+56.5%+13.2%+8.0%+3.0%+1.1%
Q1 2025+58.0%+14.9%+8.6%+3.2%+1.2%
Q2 2025+58.9%+18.0%+10.9%+3.9%+1.5%
Q3 2025+59.1%+16.7%+10.6%+3.7%+1.5%
Q4 2025+56.5%+21.8%+8.7%+3.1%+1.2%
Q1 2026+58.9%+21.9%+12.1%+4.5%+1.8%
Q2 2026+58.2%+17.7%+11.5%+4.3%+1.7%
PeriodCashDebtNet debtCurrent ratio
Q3 2024$1.1B$8.8B$7.8B1.00
Q4 2024$1.1B$8.7B$7.6B0.96
Q1 2025$1.1B$8.9B$7.8B0.86
Q2 2025$1.1B$8.7B$7.7B0.98
Q3 2025$1.1B$9.1B$8B0.98
Q4 2025$1.1B$8.5B$7.5B0.96
Q1 2026$1.1B$8.7B$7.6B0.98
Q2 2026$1.1B$8.5B$7.4B1.01
PeriodMarket capEnterprise valueP/SP/E
Q3 2024$44.3B$52.1B11.428.9
Q4 2024$40.9B$48.6B11.235.6
Q1 2025$45.9B$53.7B12.335.3
Q2 2025$40.1B$47.8B10.523.8
Q3 2025$31.3B$39.3B8.319.5
Q4 2025$32.9B$40.4B8.725.3
Q1 2026$33.1B$40.7B8.517.2
Q2 2026$36.6B$44B9.319.9

Refreshed 23m ago

Charts: revenue, profit, cash flow & valuation
Revenue$4BQ2 2026
$1B$2B$3B$4BQ3 2023: $3.9BQ4 2023: $3.7BQ1 2024: $3.9BQ2 2024: $4BQ3 2024: $3.9BQ4 2024: $3.7BQ1 2025: $3.7BQ2 2025: $3.8BQ3 2025: $3.8BQ4 2025: $3.8BQ1 2026: $3.9BQ2 2026: $4BQ3 2023Q2 2026
Net income$456MQ2 2026
$118.5M$237M$355.5M$474MQ3 2023: $438MQ4 2023: $327MQ1 2024: $296MQ2 2024: $58MQ3 2024: $383MQ4 2024: $293MQ1 2025: $322MQ2 2025: $420MQ3 2025: $398MQ4 2025: $330MQ1 2026: $474MQ2 2026: $456MQ3 2023Q2 2026
EBITDA$833MQ2 2026
$227.5M$455M$682.5M$910MQ3 2023: $838MQ4 2023: $735MQ1 2024: $685MQ2 2024: $312MQ3 2024: $855MQ4 2024: $644MQ1 2025: $701MQ2 2025: $837MQ3 2025: $760MQ4 2025: $663MQ1 2026: $910MQ2 2026: $833MQ3 2023Q2 2026
Free cash flow$826.8MQ2 2026
$206.7M$413.4M$620.1M$826.8MQ3 2023: $560MQ4 2023: $727MQ1 2024: $134MQ2 2024: $350MQ3 2024: $190MQ4 2024: $661MQ1 2025: $249MQ2 2025: $533MQ3 2025: $196MQ4 2025: $744MQ1 2026: $350MQ2 2026: $826.8MQ3 2023Q2 2026
EPS$0.24Q2 2026
$0.06$0.13$0.19$0.25Q3 2023: $0.23Q4 2023: $0.17Q1 2024: $0.15Q2 2024: $0.03Q3 2024: $0.2Q4 2024: $0.15Q1 2025: $0.17Q2 2025: $0.22Q3 2025: $0.21Q4 2025: $0.17Q1 2026: $0.25Q2 2026: $0.24Q3 2023Q2 2026
Cash / Debt$1.1BQ2 2026
$2.3B$4.6B$6.8B$9.1BQ3 2023 · Cash: $1.1BQ3 2023 · Debt: $8.4BQ4 2023 · Cash: $1.4BQ4 2023 · Debt: $8.4BQ1 2024 · Cash: $1.2BQ1 2024 · Debt: $8.7BQ2 2024 · Cash: $1BQ2 2024 · Debt: $8.6BQ3 2024 · Cash: $1.1BQ3 2024 · Debt: $8.8BQ4 2024 · Cash: $1.1BQ4 2024 · Debt: $8.7BQ1 2025 · Cash: $1.1BQ1 2025 · Debt: $8.9BQ2 2025 · Cash: $1.1BQ2 2025 · Debt: $8.7BQ3 2025 · Cash: $1.1BQ3 2025 · Debt: $9.1BQ4 2025 · Cash: $1.1BQ4 2025 · Debt: $8.5BQ1 2026 · Cash: $1.1BQ1 2026 · Debt: $8.7BQ2 2026 · Cash: $1.1BQ2 2026 · Debt: $8.5BQ3 2023Q2 2026
CashDebt
Profitability+58.2%Q2 2026
+14.8%+29.6%+44.4%+59.1%Q3 2023 · Gross margin: +57.5%Q4 2023 · Gross margin: +55.7%Q1 2024 · Gross margin: +57.6%Q2 2024 · Gross margin: +59.1%Q3 2024 · Gross margin: +58.5%Q4 2024 · Gross margin: +56.5%Q1 2025 · Gross margin: +58.0%Q2 2025 · Gross margin: +58.9%Q3 2025 · Gross margin: +59.1%Q4 2025 · Gross margin: +56.5%Q1 2026 · Gross margin: +58.9%Q2 2026 · Gross margin: +58.2%Q3 2023 · Operating margin: +18.1%Q4 2023 · Operating margin: +12.5%Q1 2024 · Operating margin: +14.1%Q2 2024 · Operating margin: +3.9%Q3 2024 · Operating margin: +16.8%Q4 2024 · Operating margin: +13.2%Q1 2025 · Operating margin: +14.9%Q2 2025 · Operating margin: +18.0%Q3 2025 · Operating margin: +16.7%Q4 2025 · Operating margin: +21.8%Q1 2026 · Operating margin: +21.9%Q2 2026 · Operating margin: +17.7%Q3 2023 · Net margin: +11.2%Q4 2023 · Net margin: +8.9%Q1 2024 · Net margin: +7.6%Q2 2024 · Net margin: +1.5%Q3 2024 · Net margin: +9.8%Q4 2024 · Net margin: +8.0%Q1 2025 · Net margin: +8.6%Q2 2025 · Net margin: +10.9%Q3 2025 · Net margin: +10.6%Q4 2025 · Net margin: +8.7%Q1 2026 · Net margin: +12.1%Q2 2026 · Net margin: +11.5%Q3 2023Q2 2026
Gross marginOperating marginNet margin
Revenue growth+3.0%Q2 2026
-1.9%+0.2%+2.4%+4.5%Q2 2024: -0.3%Q3 2024: -0.4%Q4 2024: -0.1%Q1 2025: -3.9%Q2 2025: -4.0%Q3 2025: -3.5%Q4 2025: +3.2%Q1 2026: +4.5%Q2 2026: +3.0%Q3 2023Q2 2026
Shares outstanding1.9BQ2 2026
482.3M964.5M1.4B1.9BQ3 2023: 1.9BQ4 2023: 1.9BQ1 2024: 1.9BQ2 2024: 1.9BQ3 2024: 1.9BQ4 2024: 1.9BQ1 2025: 1.9BQ2 2025: 1.9BQ3 2025: 1.9BQ4 2025: 1.9BQ1 2026: 1.9BQ2 2026: 1.9BQ3 2023Q2 2026
Valuation19.9Q2 2026
37.074.1111.1148.1Q3 2023 · P/E: 21.8Q4 2023 · P/E: 31.7Q1 2024 · P/E: 35.4Q2 2024 · P/E: 148.1Q3 2024 · P/E: 28.9Q4 2024 · P/E: 35.6Q1 2025 · P/E: 35.3Q2 2025 · P/E: 23.8Q3 2025 · P/E: 19.5Q4 2025 · P/E: 25.3Q1 2026 · P/E: 17.2Q2 2026 · P/E: 19.9Q3 2023 · P/S: 9.8Q4 2023 · P/S: 11.2Q1 2024 · P/S: 10.4Q2 2024 · P/S: 8.6Q3 2024 · P/S: 11.4Q4 2024 · P/S: 11.2Q1 2025 · P/S: 12.3Q2 2025 · P/S: 10.5Q3 2025 · P/S: 8.3Q4 2025 · P/S: 8.7Q1 2026 · P/S: 8.5Q2 2026 · P/S: 9.3Q3 2023Q2 2026
P/EP/S
Revenue$15.1B2025
$3.9B$7.7B$11.6B$15.5B2019: $14.3B2020: $14.5B2021: $15.1B2022: $15B2023: $15.4B2024: $15.5B2025: $15.1B20192025
Net income$1.5B2025
-$139.8M$599.5M$1.3B$2.1B2019: $1.4B2020: -$879M2021: $2.1B2022: $2.1B2023: $1.7B2024: $1B2025: $1.5B20192025
EBITDA$2.9B2025
$933.5M$1.9B$2.8B$3.7B2019: $3.1B2020: $3.7B2021: $3.7B2022: $3.3B2023: $3.2B2024: $2.5B2025: $2.9B20192025
Free cash flow$1.7B2025
$792M$1.6B$2.4B$3.2B2019: $2.7B2020: $3.2B2021: $39M2022: $2.2B2023: $2.7B2024: $1.3B2025: $1.7B20192025
EPS$0.762025
-$0.08$0.32$0.71$1.12019: $0.762020: -$0.472021: $1.12022: $1.082023: $0.872024: $0.542025: $0.7620192025
Cash / Debt$1.1B2025
$2.3B$4.5B$6.8B$9B2020 · Cash: $618M2020 · Debt: $02021 · Cash: $740M2021 · Debt: $129M2022 · Cash: $1.2B2022 · Debt: $9B2023 · Cash: $1.4B2023 · Debt: $8.4B2024 · Cash: $1.1B2024 · Debt: $8.7B2025 · Cash: $1.1B2025 · Debt: $8.5B20192025
CashDebt
Profitability+58.1%2025
+9.5%+25.7%+41.9%+58.1%2019 · Gross margin: +53.5%2020 · Gross margin: +54.2%2021 · Gross margin: +55.9%2022 · Gross margin: +55.4%2023 · Gross margin: +56.0%2024 · Gross margin: +58.0%2025 · Gross margin: +58.1%2019 · Operating margin: +12.9%2020 · Operating margin: -6.8%2021 · Operating margin: +19.4%2022 · Operating margin: +17.9%2023 · Operating margin: +16.3%2024 · Operating margin: +11.9%2025 · Operating margin: +17.9%2019 · Net margin: +10.0%2020 · Net margin: -6.1%2021 · Net margin: +13.8%2022 · Net margin: +13.8%2023 · Net margin: +10.8%2024 · Net margin: +6.7%2025 · Net margin: +9.7%20192025
Gross marginOperating marginNet margin
Revenue growth-2.1%2025
-0.6%+1.0%+2.5%+4.1%2020: +1.0%2021: +4.1%2022: -0.7%2023: +3.3%2024: +0.1%2025: -2.1%20192025
Shares outstanding1.9B2025
481M962M1.4B1.9B2019: 1.9B2020: 1.9B2021: 1.9B2022: 1.9B2023: 1.9B2024: 1.9B2025: 1.9B20192025
Valuation22.32025
-33.1-9.015.139.22019 · P/E: 35.42020 · P/E: -57.22021 · P/E: 24.52022 · P/E: 24.92023 · P/E: 23.92024 · P/E: 39.22025 · P/E: 22.32019 · P/S: 3.52020 · P/S: 3.52021 · P/S: 3.42022 · P/S: 3.42023 · P/S: 2.62024 · P/S: 2.62025 · P/S: 2.220192025
P/EP/S

Next catalyst

Catalysts

Earnings
2026-11-02
Revenue est. $3.9B · Updated 23m ago
Dividend
$0.21
2026-09-21

No unusual perp activity right now.

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 20261.18$15.6B+3%8
FY 20271.25$16B+6%8
FY 20281.33$16.5B+9%3
FY 20291.43$17.1B+13%1
FY 20301.43$17.4B+15%1
Q1 20270.33$4B+2%4

Company events

6
2026-11-02EarningsActual - / Estimate 0.29-
2026-09-21Dividend$0.21-
2026-08-12Dividend$0.21-
2026-08-06Earnings · Before market openActual 0.31 / Estimate 0.32Miss
2026-05-13Dividend$0.208-
2026-05-07EarningsActual 0.32 / Estimate 0.26Beat

Peer comparison

Similar listed perps
NameMarket capP/SP/EProfit marginVenues
MNST$85.6B9.340.1+23.1%3MO$119.7B5.715.1+37.8%5PEP$173B1.815.9+11.1%8MOUTAI$236.4B9.219.5+47.0%1PM$314.8B7.429.0+25.6%3PG$364.2B4.222.7+18.4%2KO$386.3B7.727.0+28.6%15COST$425.5B1.446.2+3.0%21

FMP company data

Company intelligence

Updated: Sep 22, 2026, 09:51 PM UTC

Company profile

Sector
Consumer Defensive
Industry
Household & Personal Products
Chief executive
Kirk L. Perry
Employees
21,890
IPO date
May 4, 2023
Country
US
Exchange
New York Stock Exchange
Website
Altman Z-scorei2.15
Piotroski scorei5/9
FMP ratingiB+
Owner earningsi$839.76M$0.44 per share
ESG risk ratingiBIndustry rank: 18 out of 36

Rating factors

Return on equityi
4
Return on assetsi
4
Debt to equityi
2
Price to earningsi
2
Price to booki
2

Company press releases

Kenvue Declares Quarterly Cash DividendBusiness WireKimberly-Clark Appoints Suzana Blades as Senior Vice President and General CounselPRNewsWireKenvue Reports Second Quarter 2026 ResultsBusiness WireKenvue Increases Quarterly Cash DividendBusiness WireKenvue to Announce Second Quarter 2026 Results on August 6, 2026Business WireKenvue Reports First Quarter 2026 ResultsBusiness Wire

Congressional disclosures

Senate

House

Market cap history
$33.93B-1.0%Jun 26 – Sep 26
$33.93B$35.72B$37.52BHigh: $37.52B · 2026-07-06Latest: $33.93B · 2026-09-21Jun 26Jul 26Aug 26Sep 26
Latest: $33.93B · 2026-09-21High: $37.52B · 2026-07-06Low: $33.93B · 2026-09-21
Largest fund holders
FundWeightShares held
VTI0.05%61M
VOO0.05%51M
VO0.35%41.5M
FXAIX0.06%26.8M
IVV0.05%24.1M
1657.T0.04%24.1M
1557.T0.05%23.4M
SPY0.05%23M
VTV0.13%18.3M
SDY1.48%17.6M
XLP2.23%17.5M
BALPX6.35%15.7M

Analyst track record

How the analysts covering KVUE have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings52236
Analysts1118
Buy / hold / sell6 / 46 / 0100 / 134 / 2
Upgrades / downgrades / initiations0 / 2 / 03 / 5 / 7
Price targets hit / missed6 / 38 (14%)8 / 202 (4%)
Avg. return after a rating (TipRanks)-6.6%-20.3%
Best / worst call+18.2% / -31.8%+18.2% / -38.9%

After buy calls on this stock: median 21-day move +0.4% vs S&P 500 -2.3% (n = 109)

Most accurate on this stock

Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.

  1. Nik ModiRBC Capital71% hit rate on this stock · 14 targets measuredHoldtarget $20.00Aug 7, 2026
  2. Susan AndersonCanaccord Genuity11% hit rate on this stock · 19 targets measuredBuyno targetSep 16, 2026
  3. Keith DevasJefferies0% hit rate on this stock · 10 targets measuredHoldtarget $18.00Jan 30, 2026

Latest ratings

DateAnalystCallTarget
Sep 16, 2026Susan AndersonCanaccord GenuityBuyMaintained–
Sep 14, 2026Taylor ConradArgus ResearchHoldMaintained–article ↗
Sep 14, 2026Taylor ConradArgus ResearchHoldMaintained–
Aug 11, 2026Peter GromUBSHoldMaintained$19.00article ↗
Aug 7, 2026Nik ModiRBC CapitalHoldMaintained$20.00article ↗
Consensus over the last 12 months buy hold sell avg. target month-end close
Monthly buy, hold and sell shares of analyst ratings with the average price target and the month-end close$17.50$18.00$18.50$19.00$19.50Nov 25 · Buy 4 · Hold 9 · Sell 0Nov 25Dec 25 · Buy 4 · Hold 9 · Sell 0Jan 26 · Buy 3 · Hold 10 · Sell 0Jan 26Feb 26 · Buy 3 · Hold 10 · Sell 0Mar 26 · Buy 2 · Hold 10 · Sell 0Mar 26Apr 26 · Buy 0 · Hold 8 · Sell 0May 26 · Buy 0 · Hold 8 · Sell 0May 26Jun 26 · Buy 0 · Hold 8 · Sell 0Jul 26 · Buy 0 · Hold 7 · Sell 0Jul 26Aug 26 · Buy 0 · Hold 6 · Sell 0Sep 26 · Buy 1 · Hold 6 · Sell 0Sep 26Oct 26 · Buy 1 · Hold 6 · Sell 0Nov 25 · avg. target $19.42Dec 25 · avg. target $19.42Jan 26 · avg. target $19.00Feb 26 · avg. target $19.42Mar 26 · avg. target $19.27Apr 26 · avg. target $18.57May 26 · avg. target $18.57Jun 26 · avg. target $18.57Jul 26 · avg. target $19.17Aug 26 · avg. target $19.00Sep 26 · avg. target $19.25Oct 26 · avg. target $19.25Nov 25 · month-end close $17.35Dec 25 · month-end close $17.25Jan 26 · month-end close $17.40Feb 26 · month-end close $19.12Mar 26 · month-end close $17.24Apr 26 · month-end close $17.53May 26 · month-end close $17.28Jun 26 · month-end close $19.11Jul 26 · month-end close $19.24Aug 26 · month-end close $18.88Sep 26 · month-end close $17.66Oct 26 · month-end close $17.70

Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.

TipRanks data via FMP · computed Oct 9, 2026 · 52 ratings

Other Consumer defensive perps

Embed this asset

KVUE perpetuals · perpequities.comKVUE perpetuals · perpequities.com
<a href="https://perpequities.com/stocks/kvue-perp"><img src="https://perpequities.com/badge/kvue-perp.svg" width="240" height="64" alt="KVUE perpetuals · perpequities.com" loading="lazy"></a>

Raw data: JSON · CSV · API

Next step

Stay on top of KVUE perps

Signals with a track record

Analysts who hit 70%+ of their targets on the perps we track, congress buys over $500k, 13F positions over $5M, funding spreads that have paid for days. Every post shows the evidence. Free, no sign-up.

Join on Telegram

Weekly digest by email

The listings, funding and moves that matter for KVUE — one email every Sunday.

Watchlist and alerts

Price and funding alerts for KVUE, via push or Telegram.

Set an alert

Follow the live feed

Daily movers, new listings and funding extremes as they happen.

Follow on X